A US start-up whose backers include tech billionaires Sam Altman and Peter Thiel has raised $425mn to keep it on track to ...
Donald Trump will be the first president to fully embrace digital currencies — and he’s already anointed his crypto princes ...
Helion secures funding to accelerate the development of its commercial-scale fusion power plant, aiming to deliver ...
Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's ...
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.
OpenAI CEO Sam Altman backs Retro Biosciences, a San Francisco-based biotech start-up that wants to extend human lifespan by ...
was $540 now $319 for your first year Make up your own mind. Build robust opinions on the FT's trusted journalism. Offer available until 27 February 2025.
The Silicon Valley is rife with rich and powerful men who have a philosophical commitment to "longtermism" which entails ...
Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...